Prognosis research: Why is Dr. Lydgate still waiting?

Journal of Clinical Epidemiology

Volumn 59, Issue 12, 2006, Pages 1229-1238

  Hemingway, Harry ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Existing disease; Multiplidisciplinary research; prognosis research

Indexed keywords

ARTICLE; CLINICAL PRACTICE; GENOMICS; HUMAN; LIFE EXPECTANCY; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL RESEARCH; METABOLOMICS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; PUBLIC HEALTH; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL; TAXONOMY;

EID: 33750728067     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.02.005     Document Type: Note

References (81)

1. Christakis N.A. The ellipsis of prognosis in modern medical thought. Soc Sci Med 44 (1997) 301-315
2. Elsner H.L. The prognosis of internal diseases (1923), Appleton, New York
3. Mackenzie J. Angina pectoris. London: Oxford Medical Publications; 1923.
4. Lloyd-Jones D.M., Larson M.G., Beiser A., and Levy D. Lifetime risk of developing coronary heart disease. Lancet 353 (1999) 89-92
5. Peeters A., Mamun A.A., Willekens F., and Bonneux L. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 23 (2002) 458-466
6. Woolf S.H., and Johnson R.E. A one-year audit of topics and domains in the Journal of the American Medical Association and the New England Journal of Medicine. Am J Prev Med 19 (2000) 79-86
7. SEER Cancer statistics review, 1975-2001 (2004), National Cancer Institute, Bethesda, MD
8. Warrell D.A., Cox T.M., Firth J.D., and Benz E.J. Oxford textbook of medicine (2003), Oxford University Press, Oxford
9. Anon. Clinical evidence: the international source of the best available evidence for effective healthcare (2004), BMJ Publishing, London
10. Gospodarawicz M.K., Henson D.E., Hutter R.V.P., O'Sullivan B., Sobin L.H., and Wittekind C. Prognostic factors in cancer (2001), Wiley-Liss, New York
11. Gilchrist J.M. Prognosis in neurology (2000), Butterworth-Heinemann, Boston
12. Jallon P. Prognosis of epilepsies (2003), John Libbey Eurotext, Paris
13. EVANS R.W., Baskin D.S., and Yatsu F.M. Prognosis of neurological disorders (2000), Oxford University Press, New York
14. Kapoor A.S., and Singh B.N. Prognosis and risk assessment in cardiovascular disease (1993), Churchill Livingstone, New York
15. Knottnerus J.A. Challenges in dia-prognostic research. J Epidemiol Community Health 56 (2002) 340-341
16. Nease Jr. R.F., Kneeland T., O'Connor G.T., Sumner W., Lumpkins C., Shaw L., et al. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. [published erratum appears in JAMA 1995 Aug 23-30;274(8):612]. JAMA 273 (1995) 1185-1190
17. Hilden J., and Habbema D.F. Prognosis in medicine: an analysis of its meaning and roles. Theor Med 8 (1987) 349-365
18. Morrow D.A., Antman E.M., Giugliano R.P., Cairns R., Charlesworth A., Murphy S.A., et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet 358 (2001) 1571-1575
19. Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., and Siscovick D.S. The Cardiovascular HS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341 (1999) 142-147
20. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
21. Edwards A., Elwyn G., and Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ 324 (2002) 827-830
22. Schneider E.C., and Epstein A.M. Use of public performance reports: a survey of patients undergoing cardiac surgery. JAMA 279 (1998) 1638-1642
23. Paul J.R. Clinical epidemiology (1958), University of Chicago Press, Chicago
24. Feinstein A.R. Clinical judgement (1967), Williams and Wilkins, Baltimore, MD
25. Peterson D.R. Epidemiology and clinical problems: with coordinated readings (1973), MIS Information Corp., New York
26. Fletcher R.H., and Fletcher S.W. Clinical epidemiology: the essentials (1984), Lippincott, Williams and Wilkins, Baltimore, MD
27. Feinstein A.R. Clinical epidemiology: the architecture of clinical research (1985), W.B. Saunders Company, Philadelphia
28. Sackett D.L., Haynes R.B., Guyatt G.H., and Tugwell P. Clinical epidemiology: A basic science for clinical medicine. Ed 2 (1991), Little, Brown and Co., Boston
29. Conio M., Cameron A.J., Romero Y., Branch C.D., Schleck C.D., Burgart L.J., et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 48 (2001) 304-309
30. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E., and Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353 (1999) 1547-1557
31. Ray W.A., Stein C.M., Daugherty J.R., Hall K., Arbogast P.G., and Griffin M.R. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 360 (2002) 1071-1073
32. Norris R.M., Brandt P.W., Caughey D.E., Lee A.J., and Scott P.J. A new coronary index. Lancet 1 (1969) 274-281
33. Killip III T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
34. Khot U.N., Jia G., Moliterno D.J., Lincoff A.M., Khot M.B., Harrington R.A., et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: The enduring value of Killip classification. JAMA 290 (2003) 2174-2181
35. Karnofsky D.A., and Burchenal J.H. The clinical evaluation of chemotherapeutic agents in cancer. In: McCleod C.M. (Ed). Evaluation of chemotherapeutic agents (1949), Columbia University Press, New York
36. Farr W. "On prognosis" by William Farr (British Medical Almanack 1838; Supplement 199-216) Part 1 (pages 199-208). Soz Praventivmed 48 (2003) 219-224
37. Morris J.N., Heady J.A., and Barley R.G. Prognosis of coronary heart disease in medical practitioners. Br Heart J 19 (1957) 227-232
38. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
39. Tunstall-Pedoe H., Vanuzzo D., Hobbs M., Mahonen M., Cepaitis Z., Kuulasmaa K., et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. [see comments]. Lancet 355 (2000) 688-700
40. Ho K.T., Miller T.D., Hodge D.O., Bailey K.R., and Gibbons R.J. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease. Mayo Clin Proc 77 (2002) 515-521
41. Feder G., Crook A.M., Magee P., Banerjee S., Timmis A.D., and Hemingway H. Ethnic differences in invasive management of coronary disease: prospective cohort study of patients undergoing angiography. BMJ 324 (2002) 511-516
42. Williams R.B., Barefoot J.C., Califf R.M., Haney T.L., Saunders W.B., and Pryor D.B. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 267 (1992) 520-524
43. Salomaa V., Niemela M., Miettinen H., Ketonen M., Immonen-Raiha P., Koskinen S., et al. Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation 101 (2000) 1913-1918
44. Mackay J., and Mensah G. Atlas of heart disease and stroke (2004), World Health Organisation, Geneva
45. Rothwell P.M. External validity of randomised controlled trials: "To whom do the results of this trial apply?". Lancet 365 (2005) 82-93
46. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 312 (1996) 1215-1218
47. Radford M.J., and Foody J.M. How do observational studies expand the evidence base for therapy?. JAMA 286 (2001) 1228-1230
48. Terkelsen C.J., Lassen J.F., Norgaard B.L., Gerdes J.C., Jensen T., Gotzsche L.B.-H., et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 26 (2005) 18-26
49. Poole-Wilson P.A., Lubsen J., Kirwan B.A., van Dalen F.J., Wagener G., Danchin N., et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 364 (2004) 849-857
50. Hemingway H., Crook A.M., Feder G., Banerjee S., Dawson J.R., Magee P., et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 344 (2001) 645-654
51. Sackett D.L., Haynes R.B., Tugwell P., and Guyatt P. Clinical epidemiology: a basic science for clinical medicine (1991), Lippincott, Williams and Wilkins, Baltimore, MD
52. Moher D., Schulz K.F., Altman D., and for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
53. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326 (2003) 41-44
54. Justice A.C., Covinsky K.E., and Berlin J.A. Assessing the generalizability of prognostic information. Ann Intern Med 130 (1999) 515-524
55. McGinn T.G., Guyatt G.H., Wyer P.C., Naylor C.D., Stiell I.G., Richardson W.S., et al. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA 284 (2000) 79-84
56. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004;364:911-2.
57. Laupacis A., Wells G., Richardson W.S., and Tugwell P. Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 272 (1994) 234-237
58. Ellenberg J.H., and Nelson K.B. Sample selection and the natural history of disease. Studies of febrile seizures. JAMA 243 (1980) 1337-1340
59. Hemingway H., Shipley M., McCallum A., Manderbacka K., Martikainen P., and Keskimamäki I. Angina and gender: incidence and prognosis of 121, 020 angina patients in primary care. Eur Heart J (2006) Stockholm Conf Proceeding
60. Owen-Smith V., Hannaford P.C., and Elliott A.M. Increased mortality among women with Rose angina who have not presented with ischaemic heart disease. Br J Gen Pract 53 (2003) 784-789
61. Hemingway H., Shipley M., Britton A., Page M., MacFarlane P., and Marmot M. Prognosis of angina with and without a diagnosis: 11 year follow up in the Whitehall II prospective cohort study. BMJ 327 (2003) 895
62. Serruys P.W., Unger F., Sousa J.E., Jatene A., Bonnier H.J., Schonberger J.P., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
63. Braunwald E., Domanski M.J., Fowler S.E., Geller N.L., Gersh B.J., Hsai J., et al. PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 351 (2004) 2058-2068
64. Donne J. Devotions upon emergent occasions. 1623.
65. Metcalfe C., Thompson S.G., Cowie M.R., and Sharples L.D. The use of hospital admission data as a measure of outcome in clinical studies of heart failure. Eur Heart J 24 (2003) 105-112
66. Kivimaki M., Vahtera J., Ferrie J.E., Hemingway H., and Pentti J. Organisational downsizing and musculoskeletal problems in employees: a prospective study. Occup Environ Med 58 (2001) 811-817
67. Greenwood M. Medical statistics from Graunt to Farr (1948), Cambridge University Press, New York
68. Gardner K., and Chapple A. Barriers to referral in patients with angina: qualitative study. BMJ 319 (1999) 418-421
69. Philpott S., Boynton P.M., Feder G., and Hemingway H. Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Appropriateness of Coronary Revascularisation study. Soc Sci Med 52 (2001) 1565-1575
70. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober I., Rouleau J.L., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
71. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the controlled abciximab and device investigation to lower late angioplasty complications (cadillac) trial. J Am Coll Cardiol 44 (2004) 547-553
72. Hemingway H., and Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 318 (1999) 1460-1467
73. Bogardus Jr. S.T., Concato J., and Feinstein A.R. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA 281 (1999) 1919-1926
74. Ntzani E.E., and Ioannidis J.P. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 362 (2003) 1439-1444
75. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., and Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies: an empirical assessment. Lancet 361 (2003) 567-571
76. Ransohoff D.F. Bias as a threat to the validity of cancer molecularmarker research. Nat Rev Cancer 5 (2005) 142-149
77. Lossos I.S., Czerwinski D.K., Alizadeh A.A., Wechser M.A., Tibshirani R., Botstein D., et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350 (2004) 1828-1837
78. Grunkemeier G.L., and Jin R. Receiver operating characteristic curve analysis of clinical risk models. Ann Thorac Surg 72 (2001) 323-326
79. Altman D.G., and Royston P. What do we mean by validating a prognostic model?. Stat Med 19 (2000) 453-473
80. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 274 (1995) 1591-1598
81. Diamond G.A. Future imperfect: the limitations of clinical prediction models and the limits of clinical predictions. J Am Coll Cardiol 14 (1989) 12-22